leisure time -WSS

leisure time

author：leisure time 2025-09-02 08:14:51 - browse：12

Illustration: Alex Hogan/STAT; Photo: Courtesy Perrigo

It’s not every day that a marketing team is tasked with designing the branding and packaging of the first over-the-counter birth control pill to be sold in the U.S.

This was the challenge, and the opportunity, faced by the team behind Opill, the landmark pill from drugmaker Perrigo that received approval from the Food and Drug Administration earlier this month. Their brief: Create a design that would stand out in America’s notoriously sprawling pharmacy aisles; inspire trust and confidence; be easy to remember and recognize; appeal to women — including teenagers — as well as trans men and nonbinary people; clearly communicate its purpose; be simple to carry and use; contain straightforward but accurate user information; and clear FDA requirements.

Settling on the right approach took years of research and testing, which resulted in the name Opill and packaging featuring bright teal, saturated pink, and yellow, as well as a rounded font reminiscent of millennials’ ubiquitous favorite Gotham. All of these features are intended to set the product apart from the dozens of prescription contraceptive pills available in the U.S. market and internationally.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

WSS

Ohio still needs to do more to protect the right to abortion

Warren pushes Witty on UnitedHealth's control over physicians

AI for drug discovery: Experts on separating hype from reality

Lawmakers grill UnitedHealth CEO on Change cyberattack

Ventyx halts psoriasis drug development after lackluster trial results

Readout Newsletter: Ozempic panic wanes, Legend x Novartis, etc.

focus

leisure time

focus

Cancer drug shortages should be causing more outrage

Lawmakers grill UnitedHealth CEO on Change cyberattack

Alkermes shareholders re

Crowdfunding for medical bills sidesteps core problem, author says

Drug repurposing or repositioning? The language matters

Weight loss drugs should be covered by insurers, AMA says

BioMarin wins approval for gene therapy to treat hemophilia A

First transplant of an entire human eye performed

Medicare proposal to cover medical devices draws a mixed reaction

PBM executives asked to testify by House panel

hotspot

CVS, Rite Aid closures threaten to worsen pharmacy deserts

NIH chief: government has fallen behind pharma on clinical trials

Weight loss drugs should be covered by insurers, AMA says

Type 2 diabetes prevention programs work at large scale: study

How a small hospital in rural Puerto Rico survived Hurricane Maria

Study suggests Covid rebound is far more common with Paxlovid than without

hotspot

focus

Wikipedia

focus